Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of brodalumab in psoriasis patients with prior anti-IL-17A failure
2018-000097-30Phase 4Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Feb 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brodalumab in plaque psoriasis, sponsored by Herlev & Gentofte Hospital. Started Feb 2018; status: completed.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-000097-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000097-30.